18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study

EH Elzinga, CJ van der Laken… - Journal of Nuclear …, 2011 - Soc Nuclear Med
18F-FDG PET is a sensitive, promising method for visualizing disease activity in rheumatoid
arthritis. This study aimed to assess the association between changes in 18F-FDG joint …

F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis

GW Goerres, A Forster, D Uebelhart… - Clinical nuclear …, 2006 - journals.lww.com
Materials and Methods: Seven patients with active RA underwent whole-body FDG PET and
clinical assessment before and after treatment with the antitumor necrosis factor alpha …

Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET

C Beckers, C Ribbens, B André… - Journal of Nuclear …, 2004 - Soc Nuclear Med
The aim of this study was to assess synovitis by 18F-FDG PET in an individual joint analysis
and in a global analysis of rheumatoid arthritis (RA) disease activity and to compare 18F …

The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT

K Okamura, Y Yonemoto, Y Arisaka, K Takeuchi… - …, 2012 - academic.oup.com
Objectives. To evaluate whether there is a correlation between the differences in joint uptake
of 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG) and the improvement of clinical findings in …

[HTML][HTML] 18F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab

P Fosse, MJ Kaiser, G Namur, D de Seny… - European journal of …, 2018 - Springer
Abstract Background 18 F–FDG PET/CT has been proposed in the evaluation of the disease
activity in rheumatoid arthritis (RA). The goals of this study were to evaluate the …

Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of …

A Roivainen, S Hautaniemi, T Möttönen… - European journal of …, 2013 - Springer
Purpose This study evaluated the potential of functional imaging to monitor disease activity
and response to treatment with disease-modifying antirheumatic drugs (DMARD) in DMARD …

[HTML][HTML] Potential of 18F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies

V Vijayant, M Sarma, H Aurangabadkar… - World journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To evaluate the role of fluorine-18-labeled fluorodeoxyglucose positron emission
tomography (18 F-FDG PET) in various rheumatic diseases and its potential in the early …

Total-body 18F-FDG PET/CT in autoimmune inflammatory arthritis at ultra-low dose: initial observations

Y Abdelhafez, SP Raychaudhuri, D Mazza… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Autoimmune inflammatory arthritides (AIA), such as psoriatic arthritis and rheumatoid
arthritis, are chronic systemic conditions that affect multiple joints of the body. Recently, total …

Whole-body FDG-PET/CT on rheumatoid arthritis of large joints

K Kubota, K Ito, M Morooka, T Mitsumoto… - Annals of nuclear …, 2009 - Springer
Objective Fluorodeoxyglucose (FDG) uptake in joint lesions in patients with rheumatoid
arthritis (RA) reportedly represents the degree of synovial inflammation. Most previous …

18F-FDG and 18F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis

T Watanabe, K Takase-Minegishi, A Ihata… - Modern …, 2016 - academic.oup.com
Objective. To compare the findings in rheumatoid arthritis (RA)-affected joints between 18F-
fluorodeoxyglucose (FDG) and 18F-fluoride (NaF) positron emission tomography …